Markets:

Overview

News

Currencies

International

Treasuries

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CinCor Pharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Stocks Stumbling After Thanksgiving Week ↗

November 28, 2022

The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally.

Via Talk Markets

Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher ↗

November 28, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.

Via Benzinga

CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday ↗

November 28, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Start Week On Lower Note, Dow Drops Over 100 Points ↗

November 28, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday.

Via Benzinga

CinCor Pharma Sinks After Disappointing Data From Hypertension Trial ↗

November 28, 2022

Via Benzinga

Expert Ratings for CinCor Pharma ↗

October 28, 2022

Analysts have provided the following ratings for CinCor Pharma (NASDAQ:CINC) within the last quarter:

Via Benzinga

Where CinCor Pharma Stands With Analysts ↗

October 28, 2022

Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022 ↗

October 28, 2022

Upgrades

Via Benzinga

What 4 Analyst Ratings Have To Say About CinCor Pharma ↗

October 28, 2022

Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for CinCor Pharma ↗

September 09, 2022

Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings:

Via Benzinga

4 Analysts Have This to Say About CinCor Pharma ↗

August 22, 2022

CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings within the last quarter:

Via Benzinga

CinCor Pharma Shares Trade Higher After Positive Data From Hypertension Drug ↗

August 08, 2022

Via Benzinga

3 Soaring Biotech Stocks That Could Climb Much Higher ↗

October 20, 2022

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 20, 2022

Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.

Via Benzinga

Analyst Ratings for CinCor Pharma ↗

September 09, 2022

Over the past 3 months, 5 analysts have published their opinion on CinCor Pharma (NASDAQ:CINC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Where CinCor Pharma Stands With Analysts ↗

September 09, 2022

Via Benzinga

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

These names are benefitting from M&A, clinical data and promising regulatory actions.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022 ↗

August 22, 2022

Upgrades

Via Benzinga

$18 Million Bet On This Biotechnology Stock? 4 Stocks Insiders Are Buying ↗

August 18, 2022

Although US stocks closed lower on Wednesday following the release of Fed minutes, there were a few notable insider trades.

Via Benzinga

Insiders Buy Around $70M Of 4 Stocks: Six Flags Entertainment, MGM Resorts And More ↗

August 16, 2022

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 08, 2022

Via Benzinga

Nasdaq Turns Lower; Crude Oil Rises Over 1% ↗

August 08, 2022

U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 08, 2022

Via Benzinga

Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher ↗

August 08, 2022

U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.

Via Benzinga

Why U.S. Stocks Are Trading Higher; Tyson Foods Earnings Miss Views ↗

August 08, 2022

U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 08, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

Headline News about CinCor Pharma, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today